LifeAhead
LifeAhead is a health technology company offering personalized forecasts of reproductive milestones, including fertility and menopause timelines, based on a stochastic mathematical model of ovarian follicle depletion published in Science Advances. The platform uses routine clinical biomarkers like AMH and AFC to generate probability-based predictions, designed for integration into clinical workflows so healthcare providers can guide patients in family planning decisions.
- Healthcare Technology
- Digital Health
- Data & Analytics
- Software Only
- Artificial Intelligence
Funding
Founders
Founder details are not available yet.
Product
Problem
Women face significant uncertainty about their reproductive timelines, often relying on population averages or family history that may not reflect their individual biology. This lack of personalized information makes it difficult to make informed decisions about family planning, career timing, and fertility preservation options, particularly for those concerned about early menopause or age-related fertility decline.
Solution
LifeAhead provides a computational forecasting platform that generates personalized projections of reproductive milestones, including fertility and menopause timelines, years in advance. The technology uses a novel stochastic mathematical model of ovarian follicle depletion, developed at a university and published in Science Advances, to analyze routine clinical biomarkers such as anti-Müllerian hormone (AMH) and antral follicle count (AFC). By inputting basic personal information, ultrasound data, and bloodwork, patients receive individualized probability-based forecasts rather than generic population averages. The platform is designed for straightforward integration into clinical workflows, allowing healthcare providers to interpret results with patients and guide them in making evidence-based reproductive health decisions.
Target Audience
Primary users are women seeking clarity about their reproductive timelines, particularly those concerned about early menopause or fertility planning, as well as healthcare professionals including OB/GYNs and fertility specialists who want to offer personalized forecasting to their patients.
Features
- Personalized forecasting of fertility and menopause timelines based on individual clinical biomarkers (AMH, AFC) rather than population averages
- Stochastic mathematical model of ovarian follicle depletion published in Science Advances (AAAS)
- Inputs include routine clinical measurements: basic personal information, ultrasound data, and bloodwork
- HIPAA-compliant platform designed for straightforward clinical workflow integration
- Probability-based predictions that quantify uncertainty and provide individualized risk assessment
- Interpretable results designed for clinician-guided patient counseling and family planning discussions